GRA

Grail

Stock
Stock
ISIN: US3847471014
Ticker: GRAL
US3847471014
GRAL

Price

Price

Frequently asked questions

What is Grail's market capitalization?

The market capitalization of Grail is $550.38M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

How many employees does Grail have, and what sector and industry does it belong to?

Grail employs approximately 1,370 people. It operates in the Health Care sector, specifically within the Biotechnology & Drugs industry.

What is the free float of Grail's shares?

The free float of Grail is 28.98M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 
$550.38M

Free Float

 
28.98M

Pricing

1D span
$15.92$16.49
52W span
$12.33$23.36

Information

GRAIL, Inc., formerly GRAIL, LLC, is a healthcare company, which is engaged in saving lives and shifting the paradigm in early cancer detection. It is focused on alleviating the global burden of cancer by using next-generation sequencing, population-scale clinical studies, and machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. Its targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. Its products include Galleri and Beyond. The Galleri test is a commercially available screening test for early detection of multiple types of cancer, which is termed multi-cancer early detection (MCED). Galleri screening test results can help guide next steps for a diagnosis of cancer by healthcare providers.

1,370

Biotechnology & Drugs

Health Care

Identifier

ISIN

US3847471014

Primary Ticker

GRAL

Knockouts

Join the conversation